2010
DOI: 10.1002/jcb.22870
|View full text |Cite
|
Sign up to set email alerts
|

Identification of new modulators and protein alterations in non‐apoptotic programmed cell death

Abstract: This study describes the first proteomic analysis of paraptosis—a non-apoptotic form of programmed cell death. As with apoptosis, the first description of paraptosis was based on morphological criteria. Since there are no known markers for paraptosis, the purpose of this study was to dissect changes in the proteome profile occurring during paraptosis. Using one- and two-dimensional SDS–PAGE, Western analysis, and mass spectrometry, we show that during paraptosis, alterations occur mainly in cytoskeletal protei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
66
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 62 publications
(69 citation statements)
references
References 32 publications
2
66
1
Order By: Relevance
“…Apoptosis is initiated when phosphatidylserine resides on the outer leaflet of the membrane. Loss of function and changes in conformation of PEBP conceivably could lead to loss of phospholipid asymmetry, a signal for neuronal apoptosis, which further supports the role of PEBP as a parapoptosis inhibitor (191). HNE modification of PEBP may impact lipid asymmetry as loss of activity is observed in AD and MCI and mouse models of familial AD (13,14,80) and can potentially disrupt cellular homeostasis.…”
Section: Energy Dysfunction: Atp Synthase and A-enolasementioning
confidence: 74%
“…Apoptosis is initiated when phosphatidylserine resides on the outer leaflet of the membrane. Loss of function and changes in conformation of PEBP conceivably could lead to loss of phospholipid asymmetry, a signal for neuronal apoptosis, which further supports the role of PEBP as a parapoptosis inhibitor (191). HNE modification of PEBP may impact lipid asymmetry as loss of activity is observed in AD and MCI and mouse models of familial AD (13,14,80) and can potentially disrupt cellular homeostasis.…”
Section: Energy Dysfunction: Atp Synthase and A-enolasementioning
confidence: 74%
“…Apoptosis is initiated when phosphatidylserine resides on the outer leaflet of the membrane. Loss of function and changes in conformation of PEBP conceivably could lead to loss of phospholipid asymmetry, a signal for neuronal apoptosis, which further supports the role of PEBP as a parapoptosis inhibitor (359). Loss of PEBP may impact lipid asymmetry, as loss of activity is observed in AD and MCI and mouse models of familial AD (23,24,166) and can potentially disrupt cellular homeostasis.…”
Section: Ead Carbonylated Proteinsmentioning
confidence: 75%
“…23 Paraptosis is a recently discovered form of non-apoptotic cell death, which is distinguished from apoptosis by the absence of apoptotic morphology, DNA fragmentation or caspase activation. 24 Glioblastoma cells are characterized by resistance to apoptosis, which is largely responsible for the low effectiveness of classical chemotherapeutic approaches, most of which are based on apoptosis induction. Thus, ophiobolin A is an agent with a novel mode of action (MOA) capable of overcoming apoptosis resistance in glioblastoma.…”
Section: Paal–knorr Modifications Of Biological Targets With Naturamentioning
confidence: 99%